Aaron Friedman
University of Minnesota
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron Friedman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:45 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT00135811 · Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Glomerulosclerosis, Focal · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- OPTIMAL TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSISU01DK063385 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI RICHARD N FINE · fiscal years 2002 to 2007Named on NCT00135811
- Focal Glomerulosclerosis Trial Data Coordinating CenterU01DK063490 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI Jennifer Gassman · fiscal years 2002 to 2008Named on NCT00135811
- Multicenter Trial of Focal GlomerulosclerosisU01DK063455 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DEBBIE S GIPSON · fiscal years 2002 to 2009Named on NCT00135811
- Tacrolimus vs Intensive Prednisone in Pediatric FSGSU01DK063549 · NIDDK · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI Frederick Jeffrey Kaskel · fiscal years 2002 to 2007Named on NCT00135811
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:45 UTC. The ranking covers the 200 most relevant of 229 PubMed records, and a shared surname and initials can bring in a namesake. All 229 on PubMed
- Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.J Clin Oncol · 20071,098 citationsRCR 25.8
- Combined oral contraceptives in women with systemic lupus erythematosus.N Engl J Med · 2005904 citationsRCR 23.4
- Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.Clin Cancer Res · 2007832 citationsRCR 19.4
- Recurrent Glioblastoma Treated with Recombinant Poliovirus.N Engl J Med · 2018676 citationsRCR 23.8
- 650 citationsRCR 14.4
- Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.J Clin Oncol · 1999617 citationsRCR 16.0
- Phase II trial of gefitinib in recurrent glioblastoma.J Clin Oncol · 2004590 citationsRCR 12.0
- The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial.Ann Intern Med · 2005497 citationsRCR 12.7
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.Nature · 2015442 citationsRCR 12.5
- Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas.J Neurosurg · 1991367 citationsRCR 12.1